Updated 25/05/2026
A large observational study of over 17,000 adults by researchers at the University of California, San Diego has found that women may be disproportionately sensitive to common dementia risk factors, suggesting that sex-specific prevention strategies could be critical in reducing Alzheimer’s disease burden. The UC San Diego researchers analysed longitudinal data to identify why women account for nearly two-thirds of Alzheimer’s cases in the United States.
Alzheimer’s disease burden by sex in the United States
Estimated prevalence among older adults aged 65 and over, 2024
Source: UC San Diego; Alzheimer’s Association, 2024 | Georgian Medical Journal News
Sex-specific sensitivity to established risk factors
The UC San Diego research demonstrates that women show heightened vulnerability to recognised dementia risk factors including hypertension, diabetes, and cardiovascular disease. This finding challenges the longstanding assumption that the female predominance in Alzheimer’s disease is simply attributable to women’s longer life expectancy. The study’s large sample size and longitudinal design enabled researchers to disentangle age effects from sex-specific biological and environmental mechanisms.
According to the UC San Diego study, across multiple cardiovascular and metabolic risk factors, women demonstrated steeper increases in dementia risk relative to men with equivalent exposure levels. This pattern suggests fundamental sex differences in how the brain responds to systemic physiological stress. The research aligns with The Lancet and PubMed literature highlighting sex-based variation in neurodegenerative disease pathways.
Implications for clinical prevention and screening
The UC San Diego findings suggest that current dementia prevention guidelines, which typically apply uniform thresholds for blood pressure control, glycaemic targets, and cardiovascular interventions across populations, may be suboptimal for women. The UC San Diego researchers note that if women’s brains are more sensitive to these risk factors, they may derive greater benefit from earlier and more aggressive risk factor modification. The World Health Organization and national dementia alliances are increasingly recognising sex and gender as critical variables in cognitive health strategy.
The UC San Diego team emphasises that tailored prevention represents a precision medicine approach grounded in fundamental biology, not arbitrary gender stereotyping. See our Clinical Updates section for emerging guidelines on dementia prevention in women.
Mechanistic pathways and future research directions
While the UC San Diego study establishes robust epidemiological evidence of sex-specific risk factor sensitivity, the underlying mechanisms remain incompletely understood. The researchers note that potential explanations include differential oestrogen signalling in neuroinflammation, sex-specific patterns of tau and amyloid pathology, and divergent microglial activation profiles between women and men. Recent research published in Nature Medicine and The New England Journal of Medicine has begun to illuminate these biological pathways.
The UC San Diego authors propose that understanding sex differences in Alzheimer’s biology could unlock new therapeutic targets benefiting both women and men. For deeper context, explore our New Studies coverage of dementia research.
Women demonstrate heightened sensitivity to established dementia risk factors including hypertension, diabetes, and cardiovascular disease, suggesting that sex-specific prevention strategies could significantly reduce Alzheimer’s burden in women.
— UC San Diego research team, based on analysis of 17,000+ adults in longitudinal cohort study
Key takeaways
- The UC San Diego study found that women show disproportionate sensitivity to common dementia risk factors such as hypertension, diabetes, and poor cardiovascular health.
- The research suggests that sex-specific clinical strategies may offer greater protective benefit for women than current uniform prevention guidelines.
- According to the UC San Diego researchers, mechanistic studies are needed to identify biological pathways explaining sex differences, potentially revealing new therapeutic targets.
Frequently asked questions
Why do women develop Alzheimer’s disease more often than men?
The UC San Diego study found that women are more sensitive to the effects of common risk factors like high blood pressure, diabetes, and cardiovascular disease. The research suggests biological sex differences amplify their vulnerability to these modifiable factors. This discovery opens the door to sex-tailored prevention strategies that could be more effective for women than current one-size-fits-all approaches.
Should women follow different dementia prevention guidelines than men?
Based on the UC San Diego research, women may benefit from more aggressive management of blood pressure, glucose, and cardiovascular risk at lower numerical thresholds than current recommendations suggest, though clinical guidelines have not yet been formally updated to reflect sex-specific thresholds. The researchers note that large-scale clinical trials are needed to establish evidence-based sex-stratified guidelines.
What biological mechanisms explain women’s greater sensitivity to dementia risk factors?
According to the UC San Diego researchers, the precise mechanisms are not yet fully understood, but leading hypotheses include differential oestrogen signalling in brain inflammation, sex-specific patterns of Alzheimer’s pathology accumulation, and differences in how immune cells (microglia) respond to injury. Research in PubMed is actively exploring these pathways. Understanding these mechanisms could lead to sex-specific drugs and interventions that are more effective than current treatments.
Source: Scientists discover why Alzheimer’s risk hits women so much harder
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
